MedPath
NMPA Approval

Capmatinib Hydrochloride Tablets

国药准字HJ20240041

June 11, 2024

Drug Information

盐酸卡马替尼片

妥瑞达

片剂

150mg(以C₂₃H₁₇FN₆O计)

化学药品

June 11, 2024

June 10, 2029

Company Information

Applicant Company

6343 Risch Switzerland

Manufacturing Company

Oeflinger Str. 44 79664 Wehr Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.